In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way Citeline uses cookies please go to our Cookie Policy page.


By closing this message, you are consenting to our use of cookies.

Close
 
 
 

Request a Demo of Citeline

By ticking this box, you agree to receive emails such as relevant news, updates and offers from Citeline, and carefully selected similar products from our portfolio.

By ticking this box, you agree to receive emails such as promotional offers from other members of the Informa group and selected 3rd party companies.

Real-time clinical trial, investigator, trial site and drug pipeline information to the global biopharmaceutical industry

Introducing the Citeline product family

Our integrated online tools provide the world’s most comprehensive real-time R&D intelligence

Drug development essentials

Track global clinical trials in real-time

Accurately forecast clinical trial timings

Follow every drug, from bench to market

Find the best investigator for your trial

Must-have insight

Prequalify Chinese hospitals for your clinical trials

View the clinical trials landscape

Get tailored advice for your organization

Citeline raised the bar for both pipeline databases and for clinical trials databases with their extent of integration between Trialtrove and Citeline Pipeline. Add to that the continued enhancements to data visualizations, tools for predicting trial timelines such as total duration or recruitment rates (Trialpredict), methods of evaluating study sites and Investigators (Sitetrove) and you’re looking at a rather complete package for clinical research information.

Mark Haythorn, R&D Informatics, AstraZeneca Pharmaceuticals

Collaborations in HIV treatment trials: a help or hindrance for patient recruitment?

This analysis takes a closer look at Phase II-III studies in HIV positive patients in order to determine what effect collaboration has on enrollment trends in clinical trials evaluating antiretroviral treatment.

Collaborations in HIV treatment trials: a help or hindrance for patient recruitment? Download